ACOR

Acorda Therapeutics, Inc. Press Releases

$34.23
*  
0.45
1.33%
Get ACOR Alerts
*Delayed - data as of Jul. 30, 2015  -  Find a broker to begin trading ACOR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACOR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Acorda Provides Financial and Pipeline Update for 2015 Second Quarter
7/30/2015 6:01:00 AM - Business Wire
▼-12.23 % Price Change since this news event. The Volume Ratio is 2.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Acorda Therapeutics to Host Conference Call to Discuss Second Quarter Results on July 30, 2015
7/23/2015 7:00:00 AM - Business Wire
▼-2.84 % Price Change since this news event. The Volume Ratio is 0.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda Awarded Grant to Study ARCUS® Technology in Respiratory Distress Syndrome
7/22/2015 7:00:00 AM - Business Wire
▼-0.67 % Price Change since this news event. The Volume Ratio is 0.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda Data on Inhaled Levodopa Therapy CVT-301 Recognized in Blue Ribbon Highlights Session at International Congress of Parkinson's Disease and Movement Disorders
6/24/2015 7:01:00 AM - Business Wire
▼-1.84 % Price Change since this news event. The Volume Ratio is 0.93.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda Presents Data on Inhaled Levodopa Therapy CVT-301 at International Congress of Parkinson's Disease and Movement Disorders
6/16/2015 7:00:00 AM - Business Wire
▲6.34 % Price Change since this news event. The Volume Ratio is 2.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Acorda CEO Ron Cohen Named BIO Chairman for 2015-2016 Term
6/15/2015 7:32:00 AM - Business Wire
▲8.49 % Price Change since this news event. The Volume Ratio is 3.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Digital Agency StudioPMG Wins Two Hermes Awards
6/10/2015 6:00:00 AM - PR Newswire




Acorda Therapeutics to Present at the Jefferies Global Healthcare Conference
5/26/2015 7:00:00 AM - Business Wire
▲10.42 % Price Change since this news event. The Volume Ratio is 1.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day